China Resources Double-Crane Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -8.84% vs 9.91% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -4.07% vs 29.16% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,806.60",
          "val2": "3,078.70",
          "chgp": "-8.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "524.40",
          "val2": "778.10",
          "chgp": "-32.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "7.60",
          "val2": "8.60",
          "chgp": "-11.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.50",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "501.40",
          "val2": "522.70",
          "chgp": "-4.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "186.80%",
          "val2": "189.90%",
          "chgp": "-0.31%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -1.86% vs -0.81% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 1.97% vs -0.81% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10,924.40",
          "val2": "11,131.60",
          "chgp": "-1.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,473.40",
          "val2": "2,368.70",
          "chgp": "4.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "34.70",
          "val2": "16.80",
          "chgp": "106.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "11.80",
          "val2": "-58.70",
          "chgp": "120.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,683.20",
          "val2": "1,650.70",
          "chgp": "1.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "153.70%",
          "val2": "144.80%",
          "chgp": "0.89%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

2,806.60

3,078.70

-8.84%

Operating Profit (PBDIT) excl Other Income

524.40

778.10

-32.61%

Interest

7.60

8.60

-11.63%

Exceptional Items

1.50

0.00

Consolidate Net Profit

501.40

522.70

-4.07%

Operating Profit Margin (Excl OI)

186.80%

189.90%

-0.31%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -8.84% vs 9.91% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -4.07% vs 29.16% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

10,924.40

11,131.60

-1.86%

Operating Profit (PBDIT) excl Other Income

2,473.40

2,368.70

4.42%

Interest

34.70

16.80

106.55%

Exceptional Items

11.80

-58.70

120.10%

Consolidate Net Profit

1,683.20

1,650.70

1.97%

Operating Profit Margin (Excl OI)

153.70%

144.80%

0.89%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -1.86% vs -0.81% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 1.97% vs -0.81% in Dec 2024

All Annual Results